Broker Recommendations Boston Scientific Corporation

Stocks

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 18/07/2026 am IST			After hours 05:30:00 am
44.03 ^USD	-1.32%		43.74	-0.66%

16/07	Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating	MT
16/07	Abbott raises 2026 profit forecast on heart device strength	RE

Broker Recommendations

16/07	Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating	MT
15/07	Mizuho Adjusts Price Target on Boston Scientific to $70 From $90, Maintains Outperform Rating	MT
14/07	Baird Cuts Price Target on Boston Scientific to $64 From $70, Maintains Outperform Rating	MT
14/07	Goldman Sachs Adjusts Price Target on Boston Scientific to $57 From $71, Maintains Buy Rating	MT
13/07	RBC Cuts Price Target on Boston Scientific to $85 From $100, Keeps Outperform Rating	MT
08/07	Needham Cuts Price Target on Boston Scientific to $57 From $77, Keeps Buy Rating	MT
06/07	Evercore ISI Adjusts Boston Scientific Price Target to $65 From $78	MT
25/06	Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating	MT
24/06	Jefferies Adjusts Price Target on Boston Scientific to $67 From $100, Maintains Buy Rating	MT
12/06	BofA Adjusts Price Target on Boston Scientific to $61 From $68	MT
12/06	Piper Sandler Adjusts Price Target on Boston Scientific to $65 From $90	MT
04/06	Truist Securities Cuts Price Target on Boston Scientific to $64 From $85, Maintains Buy Rating	MT
03/06	BTIG Adjusts Price Target on Boston Scientific to $65 From $80, Maintains Buy Rating	MT
29/05	TD Cowen Adjusts Price Target on Boston Scientific to $61 From $80, Maintains Buy Rating	MT
28/05	Boston Scientific's 2026 Guidance Intact Despite Watchman Headwind, RBC Capital Markets Says	MT
28/05	Citigroup Adjusts Boston Scientific Price Target to $70 From $87, Maintains Buy Rating	MT
28/05	Bernstein Adjusts Boston Scientific Price Target to $76 From $97, Maintains Outperform Rating	MT
28/05	Leerink Partners Adjusts PT on Boston Scientific to $74 From $87, Maintains Outperform Rating	MT
28/05	Wells Fargo Downgrades Boston Scientific to Equalweight From Overweight, Adjusts PT to $55 From $75	MT
28/05	Goldman Sachs Adjusts Price Target on Boston Scientific to $71 From $81, Maintains Buy Rating	MT
28/05	Barclays Adjusts Price Target on Boston Scientific to $89 From $96, Maintains Overweight Rating	MT
28/05	Nephron Research Cuts Boston Scientific Price Target to $75 From $85	MT
28/05	Baird Lowers Boston Scientific Price Target to $70 From $75	MT
27/05	Stifel Adjusts Price Target on Boston Scientific to $75 From $85, Maintains Buy Rating	MT
27/05	Goldman Sachs Adjusts Price Target on Boston Scientific to $81 From $84, Maintains Buy Rating	MT